[MigVax in The Media Line] Patient Care Compromised During Pandemic, Doctor Warns
According to Kremer-Tal, MigVax is hoping for its oral vaccine to be market-ready within 12-18 months. The company is slated to start human trials for its vaccine by the end of the summer or the beginning of the fall, she added. Read...
Read More